← Insider buys
NTLA

Intellia Therapeutics, Inc. · Healthcare

Caribou Biosciences, Inc. sold $14.7M of Intellia Therapeutics, Inc.

10% owner

Sold$14,746,273
$26.78Price
550,645Shares
−12%Stake

What NTLA did after the filing

Prices for NTLA after this filing aren't in yet.

Traded Mon, Jan 29. Filed Tue, Jan 30, 5:28 PM ET, after the close. Not investment advice.